Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
NOT YET RECRUITING
NCT07555301
Clinical Experience With Sparsentan in Switzerland in IgA Nephropathy
Sponsor: Waid City Hospital, Zurich
View on ClinicalTrials.gov
Summary
An observational study tracking the clinical course of patients with IgA nephropathy.
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
50
Start Date
2026-06-01
Completion Date
2029-12-31
Last Updated
2026-04-29
Healthy Volunteers
No
Conditions
Interventions
DRUG
sparsentan
Follow up observation of patients with IgA Nephropathy on sparsentan regarding Albuminuria and GFR
DRUG
sparsentan
follow up observation of Albuminuria and GFR in IgA patients in therapy with sparsentan
Locations (1)
Stadtspital Zurich
Zurich, Canton of Zurich, Switzerland